A link between autophagy and HER2 expression has been described in a subset of human breast carcinomas: the loss of the autophagy regulator beclin 1 correlates with HER2 amplification while patients with beclin 1 gene responded better to Tz alone or in combination with other drugs [12]. The gene discussed is BECN1; the disease is breast carcinoma.